Mylotarg (gemtuzumab ozogamicin) is a type of targeted therapy drug called a monoclonal antibody. It works by ‘targeting’ specific proteins on the surface of cells.
Mylotarg targets a protein called CD33. CD33 is found on the surface of leukaemia cells and some types of developing white blood cells. Mylotarg has two parts:
- a chemotherapy drug called ozogamicin.
Gemtuzumab locks on to the CD33 protein. It releases ozogamicin into the leukaemia cells to damage and kill them.
During treatment, you will see a cancer doctor and a cancer nurse. This is who we mean when we mention doctor or nurse in this information.